Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Transmucosal Drug Delivery Devices Market size between 2026 and 2035?
The transmucosal drug delivery devices market size has demonstrated significant growth over recent years. It is anticipated to expand from $54.63 billion in 2025 to $59.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. Historically, this market expansion can be linked to the increased adoption of non-invasive drug delivery methods, a surging demand for pain management treatments, the expanded application of hormone replacement therapies, innovations in pharmaceutical formulations, and a broader acceptance of transmucosal therapeutic approaches.
The transmucosal drug delivery devices market size is anticipated to experience robust expansion over the next few years. It is forecast to grow to $81.52 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.1%. This projected growth during the forecast period stems from the increasing development of personalized medicine solutions, rising investments in advanced drug delivery platforms, a growing demand for at-home drug administration devices, the expansion of biologics and peptide-based drugs, and an increase in regulatory approvals for novel delivery systems. Significant trends expected during this forecast period include the increasing adoption of buccal and sublingual delivery formats, a growing demand for rapid onset drug administration, the expansion of microneedle and active delivery technologies, a rising focus on patient-friendly drug delivery devices, and an enhanced emphasis on dose accuracy and bioavailability.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp
Which Drivers Are Impacting Market Performance In The Transmucosal Drug Delivery Devices Market?
The increasing incidence of chronic illnesses is anticipated to drive the expansion of the transmucosal drug delivery devices market moving ahead. A chronic disease is defined as an enduring ailment that usually advances gradually and remains present for an extended period, frequently necessitating continuous medical care to manage its signs and avert further issues. The rise in chronic conditions can be attributed to elements such as lifestyle choices, an aging global demographic, environmental influences, difficulties within healthcare systems, and increasing urbanization. For chronic diseases, transmucosal drug delivery devices serve to administer medications in a controlled and effective manner, thus maintaining consistent therapeutic concentrations to manage symptoms and enhance patient compliance. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is fueling the transmucosal drug delivery devices market.
Which Segments Are Contributing To The Growth Of The Transmucosal Drug Delivery Devices Market?
The transmucosal drug delivery devices market covered in this report is segmented –
1) By Type: Buccal Drug Delivery Devices, Sublingual Drug Delivery Devices, Nasal Drug Delivery Devices, Rectal Drug Delivery Devices, Vaginal Drug Delivery Devices
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
Subsegments:
1) By Buccal Drug Delivery Devices: Mucoadhesive Buccal Tablets, Buccal Patches, Buccal Films
2) By Sublingual Drug Delivery Devices: Sublingual Tablets, Sublingual Films, Sublingual Sprays
3) By Nasal Drug Delivery Devices: Metered Dose Nasal Sprays, Nasal Powder Devices, Nasal Gel Applicators
4) By Rectal Drug Delivery Devices: Rectal Suppositories, Rectal Gels
5) By Vaginal Drug Delivery Devices: Vaginal Rings, Vaginal Tablets, Vaginal Gels
Which Trends Are Shaping Activity Within The Transmucosal Drug Delivery Devices Market?
Major companies in transmucosal drug delivery devices are developing innovative smart platforms, including proprietary transdermal patch delivery platforms that enhance drug absorption and improve patient compliance and convenience. Proprietary transdermal patch delivery platforms are specialized technologies owned by companies for administering medications through the skin, ensuring controlled release and enhanced therapeutic outcomes. For instance, in January 2024, Starton Therapeutics Inc, a US-based biotechnology company, launched STARSILON, a novel proprietary transdermal patch delivery platform, for a longer duration to achieve therapeutic delivery of difficult-to-formulate APIs. It expands transdermal drug delivery options for challenging active pharmaceutical ingredients (APIs), enhancing therapeutic efficacy with sustained delivery rates.
Who Are The Primary Competitors In The Global Transmucosal Drug Delivery Devices Market?
Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Noven Pharmaceuticals, Antares Pharma Inc., Satsuma Pharmaceuticals Inc., AdvaCare Pharma LLP, Lifevision Healthcare Private Limited, SAVA Healthcare Limited, Kaizen Pharmaceuticals Pvt. Ltd., Maya Biotech Pvt. Ltd
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Transmucosal Drug Delivery Devices Market?
North America was the largest region in the transmucosal drug delivery devices market in 2025. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Transmucosal Drug Delivery Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp
Browse Through More Reports Similar to the Global Transmucosal Drug Delivery Devices Market 2026, By The Business Research Company
Oral Transmucosal Drugs Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-transmucosal-drugs-global-market-report
Drug Delivery Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company